{"id":"https://openalex.org/W2414705248","doi":"https://doi.org/10.1177/172460089200700416","title":"Effect of Interferon-Alpha on Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Increase during Immunotherapy with Interleukin-2","display_name":"Effect of Interferon-Alpha on Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Increase during Immunotherapy with Interleukin-2","publication_year":1992,"publication_date":"1992-10-01","ids":{"openalex":"https://openalex.org/W2414705248","doi":"https://doi.org/10.1177/172460089200700416","mag":"2414705248","pmid":"https://pubmed.ncbi.nlm.nih.gov/1491187"},"language":"en","primary_location":{"id":"doi:10.1177/172460089200700416","doi":"https://doi.org/10.1177/172460089200700416","is_oa":false,"landing_page_url":"https://doi.org/10.1177/172460089200700416","pdf_url":null,"source":{"id":"https://openalex.org/S155339466","display_name":"The International Journal of Biological Markers","issn_l":"0393-6155","issn":["0393-6155","1724-6008"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Biological Markers","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113805869","display_name":"Paolo Lissoni","orcid":"https://orcid.org/0000-0002-5374-1350","observed_orcids":["https://orcid.org/0000-0002-5374-1350"]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Lissoni","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052130645","display_name":"Antonio Ardizzoia","orcid":"https://orcid.org/0000-0003-2232-5677","observed_orcids":["https://orcid.org/0000-0003-2232-5677"]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Ardizzoia","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108516170","display_name":"Franco Rovelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Rovelli","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112152166","display_name":"Maristella Perego","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Perego","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083347871","display_name":"Paolo Cardellini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Cardellini","raw_affiliation_strings":["Division of Internal Medicine, Hospital of Vigevano (PV)- Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Internal Medicine, Hospital of Vigevano (PV)- Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110085319","display_name":"Gabriele Tancini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Tancini","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061179981","display_name":"Sandro Barni","orcid":"https://orcid.org/0000-0002-7633-0378","observed_orcids":["https://orcid.org/0000-0002-7633-0378"]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Barni","raw_affiliation_strings":["Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","Division of Internal Medicine, Hospital of Vigevano (PV)- Italy; Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]},{"raw_affiliation_string":"Division of Internal Medicine, Hospital of Vigevano (PV)- Italy; Division of Radiation Oncology, San Gerardo Hospital, Monza (MI) - Italy","institution_ids":["https://openalex.org/I4210110840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29348491,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"4","first_page":"268","last_page":"269"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.39089998602867126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.39089998602867126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.21940000355243683,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.13819999992847443,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9950000047683716},{"id":"https://openalex.org/keywords/soluble-il-2-receptor","display_name":"soluble interleukin-2 receptor","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/interleukin-2-therapy","display_name":"interleukin-2 therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cytokine-response","display_name":"cytokine response","score":0.5329999923706055},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6627131104469299},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.636038601398468},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.5526401400566101},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.5119941830635071},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.5087431073188782},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4693145751953125},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4564495086669922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41970324516296387},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40282243490219116},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3663482069969177},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32838597893714905},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27095434069633484}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/172460089200700416","doi":"https://doi.org/10.1177/172460089200700416","is_oa":false,"landing_page_url":"https://doi.org/10.1177/172460089200700416","pdf_url":null,"source":{"id":"https://openalex.org/S155339466","display_name":"The International Journal of Biological Markers","issn_l":"0393-6155","issn":["0393-6155","1724-6008"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Biological Markers","raw_type":"journal-article"},{"id":"pmid:1491187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1491187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International journal of biological markers","raw_type":"Comparative Study"},{"id":"pmh:oai:doaj.org/article:fff145fe94f348ec9b12cfdbf1b477b5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/fff145fe94f348ec9b12cfdbf1b477b5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The International Journal of Biological Markers, Vol 7 (1992)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6700000166893005,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1575437053","https://openalex.org/W1582239924","https://openalex.org/W2002724941","https://openalex.org/W2076934547","https://openalex.org/W2115446789","https://openalex.org/W2155221651"],"related_works":["https://openalex.org/W4302149482","https://openalex.org/W2470595737","https://openalex.org/W2008991346","https://openalex.org/W2474768646","https://openalex.org/W2413547133","https://openalex.org/W2407370651","https://openalex.org/W2199205868","https://openalex.org/W2079818081","https://openalex.org/W4211131765","https://openalex.org/W2415072145"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}